We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electronic Bracelet Alerts of Epileptic Seizures

By HospiMedica International staff writers
Posted on 23 Feb 2011
A novel electronic bracelet detects when the wearer begins to suffer a dangerous epileptic seizure by identifying associated characteristic limb movements.

The EpiLert bracelet is designed to respond to the needs of epilepsy patients, their caregivers, and their families, by improving the quality of patient care and reducing the anxiety of all involved by assuring a prompt alert as soon as an attack begins. More...
The EpiLert bracelet is based on a sensor that uses a proprietary algorithm to detect limb movements. The small sensor, which can be worn on the wrist or ankle, detects and processes movements and vibrations specific to epileptic seizures, and transmits the signals to the remote alert unit.

Using existing communication infrastructures--such as cellular phones, a landline telephone, internet, etc.--the alert unit will also deliver an alarm to destinations beyond the boundaries of the house, alerting the parent, caregiver, or medical assistance service within 20 to 30 seconds of the onset of a seizure. The reasoning behind the device is that prolonged seizures must be terminated as soon as possible to prevent the possibility of brain damage or even death. An added benefit is that the device also aids in the monitoring and treatment of patients by providing recordings of epileptic events and seizures data. The Epilert bracelet is under development by Biolert (Even Yehuda, Israel).

"Although there have been many attempts in the past to develop an alert of this kind, the biggest challenge has always been to find a system that could distinguish between ordinary daily movements and those movements unique to an epileptic seizure,” said Amos Shaham, MSEE, CEO and cofounder of BioLert, the company developing EpiLert. "Our breakthrough was in devising a technology that produces virtually no false alarms.”

The company also stated that follow up models will enable outdoor mobility, utilizing cell phone and global positioning system (GPS) infrastructure networks that will enable the sending of an alert together with location data to caregivers or medical emergency services (EMS) in the vicinity. In the future, it is also foreseen that the EpiLert will control the application of drugs to stop the seizure.

Related Links:
Biolert



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.